ArticleVeterinary research2025
Atypical Actinobacillus pleuropneumoniae serotype 12 strains with a higher virulence potential.
Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Actinobacillus pleuropneumoniae - today's perspective on advances and challenges (2017- 2026).BMC veterinary research · 2026Review
- Atypical multidrug-resistant serotype 1Frontiers in veterinary science · 2026Article
- Correction: Atypical Actinobacillus pleuropneumoniae serotype 12 strains with a higher virulence potential.Veterinary research · 2025Article
- Genome analysis of Actinobacillus pleuropneumoniae strain APPFJLYC01 reveals multidrug resistance and high virulence potential.PloS one · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
Actinobacillus pleuropneumoniae is the causative agent of porcine pleuropneumonia, a disease of major economic impact. Serotype 12 is generally considered to be of low virulence and is typically associated with subclinical infections. However, we describe four atypical serotype 12 field strains recovered from severe clinical outbreaks in Chile. These strains exhibited an unusual toxin gene profile (apxIICA, apxIIICA, apxIBD, apxIIIBD), suggesting the ability to produce both ApxII and ApxIII toxins. Comparative genomic analyses revealed that these atypical strains carry the capsule genes of serotype 12 but the LPS biosynthesis genes of serotype 15, indicating a hybrid genomic structure. Phylogenetic analysis confirmed that they cluster separately from classical serotype 12 strains and are closely related to other atypical strains from Japan, USA, and Canada. Experimental infection in pigs demonstrated significantly increased virulence of the atypical Chilean strain compared to the reference strain of serotype 12, with higher clinical scores, severe lung lesions, and atypical serological responses against serotypes 3/6/8/15/17. These findings challenge the traditional view of serotype 12 as low-virulence and highlight the need for improved diagnostic approaches that incorporate both capsule and LPS profiling. The existence of these atypical strains has important implications for disease surveillance, diagnostics, and vaccine development in swine health management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.